APA (7th ed.) Citation

K, B., JW, B., K, D., E, d. Z., LM, B., EM, Z., . . . WL, v. d. P. (2024). IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset. Journal of neuroinflammation, 21(1), 100. https://doi.org/10.1186/s12974-024-03090-y

Chicago Style (17th ed.) Citation

K, Budding, et al. "IgM Anti-GM2 Antibodies in Patients with Multifocal Motor Neuropathy Target Schwann Cells and Are Associated with Early Onset." Journal of Neuroinflammation 21, no. 1 (2024): 100. https://doi.org/10.1186/s12974-024-03090-y.

MLA (9th ed.) Citation

K, Budding, et al. "IgM Anti-GM2 Antibodies in Patients with Multifocal Motor Neuropathy Target Schwann Cells and Are Associated with Early Onset." Journal of Neuroinflammation, vol. 21, no. 1, 2024, p. 100, https://doi.org/10.1186/s12974-024-03090-y.